The expression levels of KCC2 and NKCC1 have been extensively characterized in the rat brain using in situ hybridization but have yet to be characterized in the human AD hippocampus [28,29,30,31,32,33,34,35,36,37]. The gene discussed is SLC12A5; the disease is Alzheimer disease.